HERMES PHARMA

hermes-pharma.com

HERMES PHARMA is the expert in developing and manufacturing user-friendly oral dosage forms - effervescent and chewable tablets, instant drinks, lozenges and orally disintegrating granules. For over 40 years, we have been working with healthcare companies around the globe to expand their product lines and grow their brands.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Business Insights

BD COMPLETES ACQUISITION OF PARATA SYSTEMS

BD | July 19, 2022

news image

BD announced it has completed the acquisition of Parata Systems. Parata advances BD's transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions that power a growing network of pharmacies to reduce costs, enhance patient safety and improve the patient experience for retail, hospital and long-term care pharmacies. As a combined company, BD is positioned to offer a comprehensive set of technologies to the $600 million pharmacy automati...

Read More

Pharmacy Market

PALATIN ANNOUNCES DIRECT-TO-CONSUMER TELEHEALTH PARTNERSHIP WITH UPSCRIPTHEALTH™ FOR VYLEESI®

PRNewswire | August 08, 2023

news image

Palatin Technologies, Inc. a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that it has entered a strategic partnership with UpScriptHealth, a leading direct-to-consumer telemedicine company providing telemedicine services to pharmaceutical and medical technology companies. Under terms of the agreement, UpScriptHealth will make Vyleesi available to the hundreds of thousands of ...

Read More

Business Insights

FUSION PHARMACEUTICALS AND NIOWAVE ANNOUNCE ACTINIUM-225 COLLABORATION AND SUPPLY AGREEMENT

Fusion Pharmaceuticals Inc. | June 13, 2022

news image

Fusion Pharmaceuticals Inc. a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as precision medicines, and Niowave, Inc., a manufacturer of medical radioisotopes from radium and uranium, today announced that the companies have entered into a collaboration and supply agreement for the development, production, and supply of actinium-225. Under the agreement, Fusion will invest up to $5 million in Niowave to further develop their technology to increase cur...

Read More

LANNETT SIGNS AGREEMENT TO BE EXCLUSIVE DISTRIBUTOR OF GENERIC FLOVENT® DISKUS®

Prnewswire | August 17, 2020

news image

Lannett Company, Inc. today announced that it has entered into an exclusive U.S. distribution agreement for the therapeutically equivalent generic of Flovent® Diskus® (Fluticasone Propionate Powder Inhaler) of Respirent Pharmaceuticals Co. Ltd. According to the Orange Book, all patents covering Flovent Diskus have expired. U.S. sales of Flovent Diskus, which have been increasing in recent years, were $94 million for the 12 months ending June, 2020 according to IQVIA, although actual gene...

Read More
news image

Business Insights

BD COMPLETES ACQUISITION OF PARATA SYSTEMS

BD | July 19, 2022

BD announced it has completed the acquisition of Parata Systems. Parata advances BD's transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions that power a growing network of pharmacies to reduce costs, enhance patient safety and improve the patient experience for retail, hospital and long-term care pharmacies. As a combined company, BD is positioned to offer a comprehensive set of technologies to the $600 million pharmacy automati...

Read More
news image

Pharmacy Market

PALATIN ANNOUNCES DIRECT-TO-CONSUMER TELEHEALTH PARTNERSHIP WITH UPSCRIPTHEALTH™ FOR VYLEESI®

PRNewswire | August 08, 2023

Palatin Technologies, Inc. a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that it has entered a strategic partnership with UpScriptHealth, a leading direct-to-consumer telemedicine company providing telemedicine services to pharmaceutical and medical technology companies. Under terms of the agreement, UpScriptHealth will make Vyleesi available to the hundreds of thousands of ...

Read More
news image

Business Insights

FUSION PHARMACEUTICALS AND NIOWAVE ANNOUNCE ACTINIUM-225 COLLABORATION AND SUPPLY AGREEMENT

Fusion Pharmaceuticals Inc. | June 13, 2022

Fusion Pharmaceuticals Inc. a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as precision medicines, and Niowave, Inc., a manufacturer of medical radioisotopes from radium and uranium, today announced that the companies have entered into a collaboration and supply agreement for the development, production, and supply of actinium-225. Under the agreement, Fusion will invest up to $5 million in Niowave to further develop their technology to increase cur...

Read More
news image

LANNETT SIGNS AGREEMENT TO BE EXCLUSIVE DISTRIBUTOR OF GENERIC FLOVENT® DISKUS®

Prnewswire | August 17, 2020

Lannett Company, Inc. today announced that it has entered into an exclusive U.S. distribution agreement for the therapeutically equivalent generic of Flovent® Diskus® (Fluticasone Propionate Powder Inhaler) of Respirent Pharmaceuticals Co. Ltd. According to the Orange Book, all patents covering Flovent Diskus have expired. U.S. sales of Flovent Diskus, which have been increasing in recent years, were $94 million for the 12 months ending June, 2020 according to IQVIA, although actual gene...

Read More

Resources

resource image

Business Insights, VIEWS AND ANALYSIS

Accubal Precision Weighing & Packaging Systems

Video

resource image

Business Insights, PHARMACY MARKET

Drug Solubility and the Need for Speed

Whitepaper

resource image

Business Insights, VIEWS AND ANALYSIS

Accubal Precision Weighing & Packaging Systems

Video

resource image

Business Insights, PHARMACY MARKET

Drug Solubility and the Need for Speed

Whitepaper

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us